A study of digestive tract cancers in young adults
Part of Cancer, Digestive system clinical trials.
This study observes people aged 18-49 with a new gastrointestinal cancer (colorectal, stomach/esophageal, or pancreatic) to learn how their lifestyle habits and tumor characteristics affect their health. By participating, you help researchers understand why these cancers occur in younger adults.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 49 years old when diagnosed with this cancer.
- You have a new diagnosis of colorectal, stomach/esophageal, or pancreatic cancer that has been confirmed by biopsy.
- Any stage of cancer or treatment plan is okay.
- You must be able to share details about your medical history and lifestyle habits.
- You have not yet started treatment for this cancer (except possibly surgery).
- If you had another cancer before, it must not have been in your digestive tract.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at colorectal cancer that starts early in life (ages 18–40). It compares it to the same cancer in people over 60 to find differences. You can join if you have had colorectal cancer and can provide a sample of your tumor.
This trial studies treatments for young adults (ages 18-39) with cancers of the digestive system or neuroendocrine tumors. It aims to find better ways to help this age group, no matter the cancer stage or grade.
This study follows young adults (ages 15-39) with gynecologic cancers to learn about their outcomes and improve care. By joining, you help researchers understand what treatments work best for people your age.
This study looks at how bacteria in your gut, your immune system, and colon cancer interact. It aims to understand these connections to improve future treatments.
This study compares patients diagnosed with colorectal cancer at a younger age (under 50) to those diagnosed later in life. By looking at tissue samples and patient surveys, researchers hope to understand differences in the disease and improve care for all ages.
This study aims to improve care for younger adults (ages 18-50) with gastrointestinal (GI) tumors. Researchers will test ways to better support patients during and after treatment. If you are 18-50 and being treated for a GI tumor at Heidelberg University Hospital, you may be able to join.
Hear when a new Early-onset Gastrointestinal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.